InvestorsHub Logo
Followers 13
Posts 1284
Boards Moderated 0
Alias Born 09/14/2015

Re: dia76ca post# 1521

Thursday, 12/08/2016 5:29:12 PM

Thursday, December 08, 2016 5:29:12 PM

Post# of 6042
There was a 3rd female caller from (I believe she said...) Amgen, seeming to critique the number of patients in the HS-110 trial.

You guys ever hear another company in the field call in to another company's conference call and question this way? It seemed unusual to me.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NHWK News